Viewing StudyNCT06025214



Ignite Creation Date: 2024-05-06 @ 7:28 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06025214
Status: RECRUITING
Last Update Posted: 2023-09-06
First Post: 2023-08-29

Brief Title: Bioequivalence Study for Fluticasone Propionate 500 mcgSalmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Sponsor: Respirent Pharmaceuticals Co Ltd
Organization: Respirent Pharmaceuticals Co Ltd

Conditions & Keywords Data

Conditions:
Name
Bioequivalence
Keywords:
Name View
ADVAIR View
bioequivalence View
fluticasone propionate View
salmeterol xinafoate View